William Henry Barth, Jr., M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cesarean Section | 11 | 2023 | 1385 | 1.680 |
Why?
|
| Uterine Contraction | 3 | 2022 | 91 | 1.470 |
Why?
|
| Placenta | 8 | 2023 | 1702 | 1.260 |
Why?
|
| Version, Fetal | 2 | 2023 | 21 | 1.090 |
Why?
|
| Breech Presentation | 2 | 2023 | 39 | 1.080 |
Why?
|
| Extraction, Obstetrical | 3 | 2015 | 28 | 1.020 |
Why?
|
| Cerclage, Cervical | 2 | 2016 | 39 | 1.020 |
Why?
|
| Obstetric Labor Complications | 3 | 2022 | 236 | 1.010 |
Why?
|
| Delivery, Obstetric | 6 | 2022 | 932 | 0.810 |
Why?
|
| Pregnancy | 49 | 2023 | 29746 | 0.800 |
Why?
|
| Pregnancy Complications, Cardiovascular | 2 | 2020 | 516 | 0.750 |
Why?
|
| Uterine Cervical Incompetence | 3 | 2016 | 29 | 0.750 |
Why?
|
| Pain, Postoperative | 3 | 2019 | 1720 | 0.680 |
Why?
|
| Treatment Refusal | 2 | 2011 | 430 | 0.610 |
Why?
|
| Premature Birth | 4 | 2015 | 1770 | 0.610 |
Why?
|
| Bupivacaine | 2 | 2018 | 413 | 0.610 |
Why?
|
| Vaginal Birth after Cesarean | 2 | 2017 | 61 | 0.590 |
Why?
|
| Placenta Diseases | 1 | 2020 | 196 | 0.590 |
Why?
|
| Placenta Accreta | 2 | 2011 | 237 | 0.590 |
Why?
|
| Patient Positioning | 1 | 2020 | 327 | 0.580 |
Why?
|
| Risk Adjustment | 1 | 2020 | 601 | 0.540 |
Why?
|
| Hyperoxia | 4 | 2022 | 250 | 0.520 |
Why?
|
| Chorioamnionitis | 3 | 2016 | 156 | 0.510 |
Why?
|
| Bed Rest | 1 | 2015 | 83 | 0.500 |
Why?
|
| Blood Transfusion | 2 | 2011 | 1328 | 0.480 |
Why?
|
| Liposomes | 1 | 2018 | 777 | 0.470 |
Why?
|
| Cervix Uteri | 3 | 2015 | 582 | 0.460 |
Why?
|
| Ultrasonography, Prenatal | 8 | 2010 | 1745 | 0.430 |
Why?
|
| Heart Diseases | 2 | 2020 | 2809 | 0.420 |
Why?
|
| Fetal Membranes, Premature Rupture | 4 | 2009 | 137 | 0.390 |
Why?
|
| Anesthetics, Local | 1 | 2018 | 1001 | 0.380 |
Why?
|
| Amniocentesis | 4 | 2016 | 115 | 0.370 |
Why?
|
| Ultrasonography, Doppler, Color | 2 | 2005 | 231 | 0.360 |
Why?
|
| Placenta Previa | 1 | 2011 | 122 | 0.340 |
Why?
|
| Uterus | 3 | 2022 | 651 | 0.330 |
Why?
|
| Forecasting | 1 | 2017 | 2931 | 0.310 |
Why?
|
| Fetoscopy | 1 | 2009 | 132 | 0.300 |
Why?
|
| Papio cynocephalus | 1 | 2005 | 2 | 0.260 |
Why?
|
| Chorionic Villi | 1 | 2005 | 53 | 0.260 |
Why?
|
| Densitometry | 1 | 2005 | 151 | 0.250 |
Why?
|
| Oxygen | 4 | 2022 | 4193 | 0.250 |
Why?
|
| Fetus | 4 | 2022 | 1859 | 0.250 |
Why?
|
| Female | 55 | 2023 | 391246 | 0.240 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2020 | 3620 | 0.240 |
Why?
|
| Pregnancy Trimester, First | 1 | 2009 | 908 | 0.240 |
Why?
|
| Hysterectomy | 3 | 2022 | 904 | 0.220 |
Why?
|
| Parakeratosis | 1 | 2002 | 2 | 0.220 |
Why?
|
| Trachea | 1 | 2009 | 1082 | 0.210 |
Why?
|
| Obstetric Labor, Premature | 3 | 2002 | 274 | 0.210 |
Why?
|
| Labor Stage, Second | 1 | 2022 | 37 | 0.200 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2022 | 36286 | 0.200 |
Why?
|
| Pregnancy Complications, Infectious | 3 | 2020 | 2125 | 0.190 |
Why?
|
| Betamethasone | 1 | 2000 | 44 | 0.180 |
Why?
|
| Serum Albumin | 1 | 2023 | 674 | 0.180 |
Why?
|
| Adrenal Cortex | 1 | 2000 | 134 | 0.170 |
Why?
|
| Gestational Age | 2 | 2008 | 3564 | 0.170 |
Why?
|
| Vaginal Smears | 1 | 2002 | 495 | 0.170 |
Why?
|
| Humans | 55 | 2023 | 760613 | 0.160 |
Why?
|
| Respiratory Insufficiency | 1 | 2008 | 1231 | 0.160 |
Why?
|
| Endometrium | 1 | 2002 | 403 | 0.160 |
Why?
|
| Pregnancy Outcome | 6 | 2020 | 2907 | 0.160 |
Why?
|
| Life Support Care | 1 | 2020 | 222 | 0.160 |
Why?
|
| Coronavirus Infections | 3 | 2020 | 3085 | 0.160 |
Why?
|
| Puerperal Disorders | 1 | 2021 | 300 | 0.150 |
Why?
|
| Pneumonia, Viral | 3 | 2020 | 3205 | 0.150 |
Why?
|
| Postoperative Complications | 1 | 2020 | 15679 | 0.150 |
Why?
|
| Pregnancy Trimester, Second | 3 | 2016 | 732 | 0.140 |
Why?
|
| Placental Insufficiency | 1 | 2017 | 50 | 0.140 |
Why?
|
| Military Personnel | 2 | 2006 | 1244 | 0.140 |
Why?
|
| Tocolytic Agents | 1 | 2016 | 24 | 0.140 |
Why?
|
| Decidua | 1 | 1996 | 82 | 0.130 |
Why?
|
| Perfusion | 1 | 2020 | 1376 | 0.130 |
Why?
|
| Nitric Oxide | 2 | 2022 | 2141 | 0.120 |
Why?
|
| Cervical Length Measurement | 1 | 2015 | 45 | 0.120 |
Why?
|
| Emergency Treatment | 1 | 2019 | 498 | 0.120 |
Why?
|
| Pregnancy in Diabetics | 1 | 1996 | 194 | 0.120 |
Why?
|
| Adult | 25 | 2022 | 220007 | 0.120 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 749 | 0.120 |
Why?
|
| Single-Blind Method | 1 | 2018 | 1578 | 0.120 |
Why?
|
| Ultrasonography | 4 | 2017 | 5961 | 0.120 |
Why?
|
| Heart Rate | 1 | 2006 | 4180 | 0.120 |
Why?
|
| Sutures | 1 | 2016 | 293 | 0.110 |
Why?
|
| Pregnancy Complications | 2 | 2012 | 2942 | 0.110 |
Why?
|
| Prenatal Care | 1 | 2021 | 1129 | 0.110 |
Why?
|
| Diabetes, Gestational | 1 | 2023 | 1242 | 0.110 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2020 | 1431 | 0.110 |
Why?
|
| Hydrocortisone | 1 | 2000 | 1803 | 0.100 |
Why?
|
| Contrast Media | 1 | 2005 | 5305 | 0.100 |
Why?
|
| Ectodermal Dysplasia | 1 | 2012 | 106 | 0.090 |
Why?
|
| Infant, Newborn | 8 | 2022 | 26179 | 0.090 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2000 | 1796 | 0.090 |
Why?
|
| Blood Pressure | 2 | 2006 | 8525 | 0.090 |
Why?
|
| alpha-Fetoproteins | 1 | 1991 | 222 | 0.090 |
Why?
|
| Hemostatic Techniques | 1 | 2011 | 114 | 0.090 |
Why?
|
| Stress, Psychological | 1 | 2006 | 4446 | 0.090 |
Why?
|
| Laryngostenosis | 1 | 2012 | 167 | 0.090 |
Why?
|
| Physical Examination | 1 | 2016 | 1244 | 0.090 |
Why?
|
| Vasa Previa | 1 | 2010 | 32 | 0.080 |
Why?
|
| Emergencies | 1 | 2016 | 1210 | 0.080 |
Why?
|
| Fetal Organ Maturity | 1 | 2009 | 83 | 0.080 |
Why?
|
| Personal Autonomy | 1 | 2011 | 302 | 0.080 |
Why?
|
| Mortality | 1 | 2020 | 2916 | 0.080 |
Why?
|
| Trial of Labor | 2 | 2022 | 81 | 0.080 |
Why?
|
| Pre-Eclampsia | 1 | 1998 | 1229 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2010 | 17790 | 0.080 |
Why?
|
| Perioperative Care | 1 | 2016 | 1037 | 0.080 |
Why?
|
| Venous Thromboembolism | 1 | 2021 | 1864 | 0.080 |
Why?
|
| Pain Measurement | 1 | 2018 | 3527 | 0.080 |
Why?
|
| Religion | 1 | 2011 | 376 | 0.070 |
Why?
|
| Blood Flow Velocity | 2 | 2005 | 1377 | 0.070 |
Why?
|
| Aneuploidy | 1 | 1991 | 551 | 0.070 |
Why?
|
| Blood Loss, Surgical | 1 | 2011 | 656 | 0.070 |
Why?
|
| Labor, Induced | 3 | 1997 | 151 | 0.070 |
Why?
|
| Mouth Diseases | 1 | 2009 | 238 | 0.070 |
Why?
|
| Fetal Diseases | 2 | 2009 | 911 | 0.070 |
Why?
|
| Labor, Obstetric | 1 | 2009 | 321 | 0.070 |
Why?
|
| Ethics, Medical | 1 | 2011 | 783 | 0.070 |
Why?
|
| Aspirin | 1 | 1998 | 3364 | 0.060 |
Why?
|
| Hydranencephaly | 1 | 2005 | 5 | 0.060 |
Why?
|
| Postpartum Period | 2 | 2023 | 1168 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 6544 | 0.060 |
Why?
|
| Chromosome Aberrations | 1 | 1991 | 1767 | 0.060 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2009 | 1096 | 0.060 |
Why?
|
| Cytomegalovirus | 1 | 2009 | 755 | 0.060 |
Why?
|
| Mass Screening | 1 | 2020 | 5422 | 0.060 |
Why?
|
| Oxytocin | 3 | 1997 | 401 | 0.060 |
Why?
|
| Massachusetts | 2 | 2020 | 8803 | 0.060 |
Why?
|
| Patient Selection | 1 | 2016 | 4279 | 0.060 |
Why?
|
| Cysts | 1 | 2009 | 683 | 0.060 |
Why?
|
| Pregnancy, Multiple | 2 | 2010 | 215 | 0.050 |
Why?
|
| Fetal Movement | 1 | 2022 | 21 | 0.050 |
Why?
|
| Adaptation, Physiological | 1 | 2009 | 1296 | 0.050 |
Why?
|
| Analgesics, Opioid | 1 | 2019 | 3763 | 0.050 |
Why?
|
| Meconium Aspiration Syndrome | 1 | 2002 | 30 | 0.050 |
Why?
|
| Retrospective Studies | 8 | 2023 | 80345 | 0.050 |
Why?
|
| Cytomegalovirus Infections | 1 | 2009 | 831 | 0.050 |
Why?
|
| Fallopian Tube Diseases | 1 | 2002 | 60 | 0.050 |
Why?
|
| Parity | 2 | 2023 | 925 | 0.050 |
Why?
|
| United States | 5 | 2021 | 72448 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1996 | 3454 | 0.050 |
Why?
|
| Pilot Projects | 2 | 2023 | 8556 | 0.050 |
Why?
|
| Uterine Diseases | 1 | 2002 | 117 | 0.050 |
Why?
|
| Adrenal Cortex Function Tests | 1 | 2000 | 12 | 0.050 |
Why?
|
| Abruptio Placentae | 1 | 2002 | 118 | 0.050 |
Why?
|
| Placental Circulation | 1 | 2020 | 37 | 0.050 |
Why?
|
| Uterine Hemorrhage | 1 | 2002 | 242 | 0.040 |
Why?
|
| Glucose Tolerance Test | 1 | 2023 | 1174 | 0.040 |
Why?
|
| Video Recording | 1 | 2005 | 955 | 0.040 |
Why?
|
| Peripartum Period | 1 | 2021 | 138 | 0.040 |
Why?
|
| Young Adult | 4 | 2022 | 58748 | 0.040 |
Why?
|
| Risk Factors | 6 | 2021 | 74333 | 0.040 |
Why?
|
| Tumor Virus Infections | 1 | 2002 | 438 | 0.040 |
Why?
|
| Asymptomatic Infections | 1 | 2020 | 131 | 0.040 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2002 | 582 | 0.040 |
Why?
|
| Injections, Intramuscular | 1 | 2000 | 553 | 0.040 |
Why?
|
| Models, Animal | 1 | 2005 | 2117 | 0.040 |
Why?
|
| Obstetrics | 2 | 2002 | 667 | 0.040 |
Why?
|
| Postpartum Hemorrhage | 1 | 2022 | 265 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2010 | 9716 | 0.040 |
Why?
|
| Prospective Studies | 5 | 2022 | 54306 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2016 | 7408 | 0.040 |
Why?
|
| Administration, Inhalation | 1 | 2020 | 1156 | 0.040 |
Why?
|
| Boston | 2 | 2020 | 9278 | 0.040 |
Why?
|
| Oxytocics | 1 | 1997 | 65 | 0.040 |
Why?
|
| Vagina | 1 | 2002 | 837 | 0.040 |
Why?
|
| Heart | 1 | 2009 | 4393 | 0.030 |
Why?
|
| Papillomaviridae | 1 | 2002 | 1117 | 0.030 |
Why?
|
| Medical Records | 1 | 2002 | 1407 | 0.030 |
Why?
|
| Pandemics | 3 | 2020 | 8623 | 0.030 |
Why?
|
| Linear Models | 1 | 2006 | 5877 | 0.030 |
Why?
|
| Cesarean Section, Repeat | 1 | 1995 | 29 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2020 | 64981 | 0.030 |
Why?
|
| Tocolysis | 1 | 1994 | 18 | 0.030 |
Why?
|
| Image Enhancement | 1 | 2005 | 2881 | 0.030 |
Why?
|
| Diethylstilbestrol | 1 | 1994 | 88 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2005 | 5201 | 0.030 |
Why?
|
| Prevalence | 3 | 2020 | 15686 | 0.030 |
Why?
|
| Logistic Models | 2 | 2008 | 13312 | 0.030 |
Why?
|
| Indomethacin | 1 | 1994 | 326 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2015 | 24102 | 0.030 |
Why?
|
| Twins | 2 | 2010 | 339 | 0.030 |
Why?
|
| Cross-Sectional Studies | 4 | 2022 | 25941 | 0.030 |
Why?
|
| Postmenopause | 1 | 2002 | 2509 | 0.030 |
Why?
|
| Organ Size | 1 | 2017 | 2254 | 0.020 |
Why?
|
| Middle Aged | 7 | 2022 | 220359 | 0.020 |
Why?
|
| Cerebrovascular Disorders | 1 | 1998 | 1501 | 0.020 |
Why?
|
| Microcirculation | 1 | 1996 | 1278 | 0.020 |
Why?
|
| Arteries | 1 | 1996 | 1126 | 0.020 |
Why?
|
| Hypercholesterolemia | 1 | 1998 | 1155 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2006 | 12531 | 0.020 |
Why?
|
| Papillomavirus Infections | 1 | 2002 | 1607 | 0.020 |
Why?
|
| Biopsy | 1 | 2002 | 6771 | 0.020 |
Why?
|
| Methods | 1 | 1990 | 1074 | 0.020 |
Why?
|
| Ontario | 1 | 2010 | 404 | 0.020 |
Why?
|
| Karyotyping | 1 | 1991 | 1172 | 0.020 |
Why?
|
| Africa, Eastern | 1 | 2009 | 76 | 0.020 |
Why?
|
| Mouth Floor | 1 | 2009 | 38 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2023 | 6379 | 0.020 |
Why?
|
| Fever of Unknown Origin | 1 | 2009 | 94 | 0.020 |
Why?
|
| Tracheomalacia | 1 | 2009 | 63 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2002 | 41337 | 0.020 |
Why?
|
| Blood Coagulation | 1 | 1994 | 1157 | 0.020 |
Why?
|
| Dilatation, Pathologic | 1 | 1990 | 527 | 0.020 |
Why?
|
| Incidence | 3 | 2021 | 21391 | 0.020 |
Why?
|
| Chromosome Disorders | 1 | 1991 | 499 | 0.020 |
Why?
|
| Viremia | 1 | 2009 | 707 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2021 | 8022 | 0.020 |
Why?
|
| Tracheostomy | 1 | 2009 | 425 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2021 | 8950 | 0.010 |
Why?
|
| Immunoglobulin M | 1 | 2009 | 1529 | 0.010 |
Why?
|
| Aging | 1 | 2002 | 8652 | 0.010 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2010 | 1723 | 0.010 |
Why?
|
| Life Expectancy | 1 | 2010 | 1247 | 0.010 |
Why?
|
| Travel | 1 | 2009 | 785 | 0.010 |
Why?
|
| Pregnancy, Prolonged | 1 | 2002 | 9 | 0.010 |
Why?
|
| World Health Organization | 2 | 1998 | 1314 | 0.010 |
Why?
|
| Fetal Monitoring | 1 | 2002 | 69 | 0.010 |
Why?
|
| Heart Rate, Fetal | 1 | 2002 | 75 | 0.010 |
Why?
|
| Prenatal Diagnosis | 1 | 2009 | 1264 | 0.010 |
Why?
|
| Liver | 1 | 2017 | 7510 | 0.010 |
Why?
|
| Smoking | 1 | 1998 | 9073 | 0.010 |
Why?
|
| Aged | 3 | 2002 | 169143 | 0.010 |
Why?
|
| Animals | 2 | 2019 | 167960 | 0.010 |
Why?
|
| Time Factors | 1 | 2021 | 40139 | 0.010 |
Why?
|
| Germany, East | 1 | 1998 | 6 | 0.010 |
Why?
|
| Adolescent | 3 | 2022 | 87809 | 0.010 |
Why?
|
| Hypertension | 1 | 1998 | 8595 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 1994 | 10343 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2002 | 58980 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2010 | 5508 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2009 | 4542 | 0.010 |
Why?
|
| Germany | 1 | 1998 | 873 | 0.010 |
Why?
|
| Obesity | 1 | 1998 | 12919 | 0.010 |
Why?
|
| Metabolic Clearance Rate | 1 | 1996 | 361 | 0.010 |
Why?
|
| Hospitals, Military | 1 | 1995 | 62 | 0.010 |
Why?
|
| Bleeding Time | 1 | 1994 | 84 | 0.010 |
Why?
|
| Prothrombin Time | 1 | 1994 | 116 | 0.010 |
Why?
|
| Texas | 1 | 1995 | 401 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2017 | 23374 | 0.010 |
Why?
|
| Partial Thromboplastin Time | 1 | 1994 | 206 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2009 | 12968 | 0.010 |
Why?
|
| Male | 3 | 2008 | 359718 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 1998 | 2932 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 1998 | 15760 | 0.010 |
Why?
|
| Maternal Age | 1 | 1995 | 807 | 0.010 |
Why?
|
| Brain | 1 | 2017 | 26951 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 14661 | 0.010 |
Why?
|
| Administration, Oral | 1 | 1994 | 4035 | 0.000 |
Why?
|
| Regression Analysis | 1 | 1996 | 6359 | 0.000 |
Why?
|
| Recurrence | 1 | 1998 | 8483 | 0.000 |
Why?
|
| Survival Analysis | 1 | 1998 | 10185 | 0.000 |
Why?
|
| Vacuum | 1 | 1965 | 65 | 0.000 |
Why?
|
| Sex Factors | 1 | 1998 | 10546 | 0.000 |
Why?
|
| Registries | 1 | 1998 | 8458 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2005 | 20509 | 0.000 |
Why?
|
| Body Mass Index | 1 | 1998 | 12914 | 0.000 |
Why?
|
| Case-Control Studies | 1 | 1997 | 22052 | 0.000 |
Why?
|